ARCHIVES

Tracor Could Earn $186,000 As Prime Contractor On Carcinogenesis Bioassay

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | April 26, 1974

Download PDF Visit The Full Archive

Related Articles

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

DCCP Board Okays New Projects In Chemoprevention, Other Programs Totaling $5 Million In First Year

December 14, 1979

Final Issue Of the Year

December 14, 1990

Patient Advocacy: congress Delivers Symbolism, Not Solution, Visco Says

October 17, 1997

Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months

May 31, 2013

Funding Opportunities

December 13, 2002